Streetinsider.com's Hot Lunchtime Reads 9/16: (SGYP) (BIIB) (JNJ) (RVNC)

September 16, 2016 12:13 PM EDT

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

The following is a list of notable articles to help get you through the lunch hour:
  • Language in Debt Offering Suggests Gilead's (GILD) M&A Team is Ready to Pounce - Jefferies -> Read this!

  • Revance Therapeutics (RVNC) Sees Strong Upside on Volume -> Read this!

  • Arena Pharma (ARNA) Shares See Profit Taking Following Strong Session -> Read this!

  • Johnson & Johnson (JNJ) on Watch Amid Unconfirmed Activist-Related Rumors -> Read this!

  • Biogen's (BIIB) Anti-LINGO Data Better then Expected; Stifel Affirms at 'Hold' -> Read this!

  • BTIG Affirms 'Buy' Rating on Synergy Pharma (SGYP) Ahead of Pivotal Plecanatide Data in IBS-C -> Read this!



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Special Reports

Related Entities

Stifel, Jefferies & Co, BTIG

Add Your Comment